ADRs End With Gains; TC BioPharm Climbs 38%
This article was automatically generated by MarketWatch using technology from Automated Insights.
International stocks trading in New York closed higher on Friday, as the S&P/BNY Mellon index of American depositary receipts added 0.3% to 171.36.
The European index rose 0.4% to 164.93. The Asian index rose 0.3% to 201.31. The Latin American index added 0.3% to 215.76, while the emerging-markets index rose 0.4% to 323.88.
The U.K.'s TC BioPharm was the biggest leader during the session, soaring 38% to $1.52, and Connect Biopharma, which is based in China, gained 26% to $1.40.
Renalytix, based in the U.K., posted the largest decline, dropping almost 30% to 38 cents, followed by shares of China's Viomi Technology down about 24% to 77 cents. Shares of China-based TuanChe lost about 15% to close at $1.87.
Data source: Dow Jones Market Data, FactSet.
(END) Dow Jones Newswires
February 09, 2024 16:51 ET (21:51 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth